{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:04:40Z","timestamp":1791590680449,"version":"4.3.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Dynamic prognostic information is crucial for treatment decisions and patient consultations in extrahepatic bile duct (EHBD) cancer, given its poor prognosis. This study aimed to investigate the long-term conditional relative survival (CRS) rates among patients with EHBD cancer in Korea, where its incidence is notably high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>Data from 46\u2009916 individuals diagnosed with EHBD cancer between 1999 and 2021 were obtained from the Korea Central Cancer Registry (KCCR) for this retrospective cohort study. CRS was analyzed according to various strata, including the Surveillance, Epidemiology, and End Results (SEER) stage and the first course of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The 5-year survival probability at diagnosis was 20.8%, whereas the conditional probability of surviving to the fifth year for patients who had already survived 1, 2, 3, and 4\u00a0years after diagnosis (the probability of surviving an additional 4, 3, 2, and 1 year) was 35.4%, 55.5%, 74.0%, and 88.6%, respectively. Among the 5-year survivors, 72.4% lived for an additional 5\u00a0years. For patients who underwent surgery at the localized or regional stage, the 5-year survival rates at diagnosis were 53.5% and 34.7%, respectively. Among 2-year survivors, 71.7% (localized) and 56.6% (regional) survived to the 5 years after diagnosis, and among 5-year survivors, 73.0% (localized) and 69.0% (regional) lived for an additional 5\u00a0years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The long-term survival rate among patients with EHBD cancer did not plateau, even among 5-year survivors with localized-stage disease, as it continued to decline over time. These findings suggest that continued surveillance and individualized assessments are warranted for patients with EHBD cancer throughout long-term follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004593","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:08:31Z","timestamp":1770905311000},"page":"10010-10020","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Long-term conditional relative survival trends in extrahepatic bile duct cancer: insights from a population-based retrospective cohort study in a high-incidence Asian Country, 1999\u20132021"],"prefix":"10.1097","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-3808","authenticated-orcid":false,"given":"Mee Joo","family":"Kang","sequence":"first","affiliation":[{"name":"Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea"},{"name":"Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johyun","family":"Ha","sequence":"additional","affiliation":[{"name":"Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Jae","family":"Park","sequence":"additional","affiliation":[{"name":"Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Min","family":"Park","sequence":"additional","affiliation":[{"name":"Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Won","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Sik","family":"Han","sequence":"additional","affiliation":[{"name":"Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"R1-20260424","doi-asserted-by":"crossref","first-page":"663\u201373","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (bilcap): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"R2-20260424","doi-asserted-by":"crossref","first-page":"107064","DOI":"10.1016\/j.ejso.2023.107064","article-title":"Epidemiology of cholangiocarcinoma","volume":"51","author":"Qurashi","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"R3-20260424","doi-asserted-by":"crossref","first-page":"220\u201328","DOI":"10.14701\/ahbps.22-041","article-title":"Incidence, mortality and survival of gallbladder, extrahepatic bile duct, and pancreatic cancer using Korea Central Cancer Registry database: 1999-2019","volume":"26","author":"Kang","year":"2022","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"R4-20260424","first-page":"1178\u201389","article-title":"Conditional relative survival of exocrine pancreatic cancer: a population-based study","volume":"31","author":"Kang","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"R5-20260424","doi-asserted-by":"crossref","first-page":"1530\u201336","DOI":"10.1158\/1078-0432.CCR-14-2154","article-title":"Conditional survival: a useful concept to provide information on how prognosis evolves over time","volume":"21","author":"Hieke","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R6-20260424","doi-asserted-by":"crossref","first-page":"5938\u201343","DOI":"10.1200\/JCO.2009.23.1860","article-title":"Practical application of a calculator for conditional survival in colon cancer","volume":"27","author":"Chang","year":"2009","journal-title":"J Clin Oncol"},{"key":"R7-20260424","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/SLA.0000000000004473","article-title":"Conditional survival of patients who underwent curative resection for esophageal squamous cell carcinoma","volume":"276","author":"Shin","year":"2022","journal-title":"Ann Surg"},{"key":"R8-20260424","doi-asserted-by":"crossref","first-page":"510\u201317","DOI":"10.1016\/j.hpb.2016.04.001","article-title":"Conditional probability of long-term survival after resection of hilar cholangiocarcinoma","volume":"18","author":"Buettner","year":"2016","journal-title":"HPB (Oxford)"},{"key":"R9-20260424","doi-asserted-by":"crossref","first-page":"966\u201371","DOI":"10.1016\/j.hpb.2017.07.004","article-title":"Conditional survival in patients with unresectable perihilar cholangiocarcinoma","volume":"19","author":"Gaspersz","year":"2017","journal-title":"HPB (Oxford)"},{"key":"R10-20260424","doi-asserted-by":"crossref","first-page":"740\u201350","DOI":"10.1002\/jhbp.916","article-title":"Impact of changes in the topographic classification of klatskin tumor on incidence of intra- and extrahepatic bile duct cancer: a population-based national cancer registry study","volume":"28","author":"Kang","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R11-20260424","doi-asserted-by":"crossref","first-page":"1690\u201398","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"key":"R12-20260424","first-page":"100081","article-title":"Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R13-20260424","doi-asserted-by":"crossref","first-page":"330\u201344","DOI":"10.4143\/crt.2022.128","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019","volume":"54","author":"Kang","year":"2022","journal-title":"Cancer Res Treat"},{"key":"R14-20260424","doi-asserted-by":"crossref","first-page":"357\u201371","DOI":"10.4143\/crt.2024.253","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2021","volume":"56","author":"Park","year":"2024","journal-title":"Cancer Res Treat"},{"key":"R18-20260424","doi-asserted-by":"crossref","first-page":"208\u201317","DOI":"10.4143\/crt.2021.421","article-title":"First course of treatment and prognosis of exocrine pancreatic cancer in Korea from 2006 to 2017","volume":"54","author":"Kang","year":"2022","journal-title":"Cancer Res Treat"},{"key":"R21-20260424","first-page":"101\u201321","article-title":"The relative survival rate: a statistical methodology","volume":"6","author":"Ederer","year":"1961","journal-title":"Natl Cancer Inst Monogr"},{"key":"R22-20260424","doi-asserted-by":"crossref","first-page":"1061\u201368","DOI":"10.1038\/s41416-022-01866-8","article-title":"Obtaining long-term stage-specific relative survival estimates in the presence of incomplete historical stage information","volume":"127","author":"Stannard","year":"2022","journal-title":"Br J Cancer"},{"key":"R23-20260424","doi-asserted-by":"crossref","first-page":"2389\u2013430","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med"},{"key":"R24-20260424","doi-asserted-by":"crossref","first-page":"1148\u201355","DOI":"10.1097\/SLA.0000000000003083","article-title":"Reappraising the concept of conditional survival after pancreatectomy for ductal adenocarcinoma: a bi-institutional analysis","volume":"271","author":"Malleo","year":"2020","journal-title":"Ann Surg"},{"key":"R25-20260424","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1245\/s10434-025-17237-5","article-title":"Conditional relative survival of gallbladder cancer: a population-based study in a high-incidence asian country from 1999 to 2021","author":"Kang","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"R26-20260424","doi-asserted-by":"crossref","first-page":"8549487","DOI":"10.1155\/2022\/8549487","article-title":"Treatment response and conditional survival in advanced pancreatic cancer patients treated with FOLFIRINOX: a multicenter cohort study","volume":"2022","author":"van der Sijde","year":"2022","journal-title":"J Oncol"},{"key":"R27-20260424","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12957-015-0608-4","article-title":"Conditional survival of pancreatic ductal adenocarcinoma in surgical and nonsurgical patients: a retrospective analysis report from a single institution in China","volume":"13","author":"Liao","year":"2015","journal-title":"World J Surg Oncol"},{"key":"R28-20260424","doi-asserted-by":"crossref","first-page":"2516\u201324","DOI":"10.1245\/s10434-020-08235-w","article-title":"Conditional survival after resection for pancreatic cancer: a population-based study and prediction model","volume":"27","author":"Latenstein","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R29-20260424","first-page":"1041\u201349","article-title":"Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection","volume":"221","author":"Groot Koerkamp","year":"2015","journal-title":"J Am Coll Surg"},{"key":"R30-20260424","first-page":"2919\u201329","article-title":"Defining early recurrence of hilar cholangiocarcinoma after curative-intent surgery: a multi-institutional study from the us extrahepatic biliary malignancy consortium","volume":"42","author":"Zhang","year":"2018","journal-title":"World J Surg"},{"key":"R31-20260424","doi-asserted-by":"crossref","first-page":"19\u201331","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"},{"key":"R32-20260424","doi-asserted-by":"crossref","first-page":"335\u201343","DOI":"10.1007\/s11605-009-1072-7","article-title":"Surgical management of infrahilar\/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients","volume":"14","author":"Sakamoto","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R33-20260424","doi-asserted-by":"crossref","first-page":"575\u201381","DOI":"10.1111\/hpb.12193","article-title":"Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin","volume":"16","author":"Han","year":"2014","journal-title":"HPB (Oxford)"},{"key":"R34-20260424","doi-asserted-by":"crossref","first-page":"1788\u201396","DOI":"10.1007\/s00268-007-9102-7","article-title":"Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangio-carcinoma","volume":"31","author":"Sasaki","year":"2007","journal-title":"World J Surg"},{"key":"R35-20260424","doi-asserted-by":"crossref","first-page":"1230\u201337","DOI":"10.6004\/jnccn.2020.7568","article-title":"Conditional survival and cure of patients with colon or rectal cancer: a population-based study","volume":"18","author":"Qaderi","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"R40-20260424","doi-asserted-by":"crossref","first-page":"e46737","DOI":"10.2196\/46737","article-title":"Predicting lung cancer survival to the future: population-based cancer survival modeling study","volume":"10","author":"Meng","year":"2024","journal-title":"JMIR Public Health Surveill"},{"key":"R41-20260424","doi-asserted-by":"crossref","first-page":"1961\u201368","DOI":"10.1093\/aje\/kwab121","article-title":"A survivorship-period-cohort model for cancer survival: application to liver cancer in taiwan, 1997-2016","volume":"190","author":"Peng","year":"2021","journal-title":"Am J Epidemiol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:03:31Z","timestamp":1777057411000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004593","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"2025-06-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}